OKYO OKYO Pharma Limited
$1.49▲ +3.47%
Healthcare
Other
Volume 11.3K
Avg Volume (10D) 53.0K
Key Metrics & Fundamentals
Market Cap
$78.19M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.27 - 3.20
% vs 50 MA
3.15%
% vs 200 MA
-8.99%
RSI-14
55.2
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.41
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
OKYO Pharma enrolls first patients in Phase 3 trial of neuropathic corneal pain drug
Proactive · Oct 6, 2026 8:30 AM ET
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
GlobeNewswire · Oct 6, 2026 7:00 AM ET
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
GlobeNewswire · Sep 29, 2026 7:00 AM ET
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
GlobeNewswire · Sep 9, 2026 7:00 AM ET
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
GlobeNewswire · Sep 8, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.